SDShengcheng Dong

Shengcheng Dong

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Shengcheng Dong has a total of 115 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    A scalable approach to resolving variants of uncertain significance

    by Malvika Tejura, Yile Chen, Abbye E. McEwen, Ross Stewart, Yuriy Sverchkov, Florent Laval, Ivan Woo, Daniel Zeiberg, Runxi Shen, Shawn Fayer, et al.

    Over 90% of missense variants across ∼4,000 disease-associated genes are variants of uncertain significance (VUS). Experimental variant effect measurements provide critical evidence about pathogenicity and inform disease biology, but most variants lack data and clinical translation has been limited. The Impact of Genomic Variation on Function Consortium generated experimental data for 62,215 variants across ten genes using multiplexed assays and 1,407 variants across 163 genes using arrayed assays, curated 193,139 additional community-generated variant effect measurements across 30 additional genes, and developed automated calibration methods for translating experimental data and variant effect predictions into clinical evidence. To reduce current VUS, we developed a scalable workflow using only experimental and predictive evidence, enabling reclassification of 75% of the 16,115 VUS in these genes as pathogenic or benign with 90,000 unobserved variants; 62% had enough evidence to be “preclassified” as pathogenic or benign. We validated our data, evidence and classifications using All of Us and created interactive resources to enable clinical use of the calibrated data. Thus, for 40 genes, representing 1% of the clinical genome, we resolve most existing VUS and future variants, illustrating how systematic use of scalable evidence can empower genomic medicine.


  • Open Access

    Organ-specific prioritization and annotation of non-coding regulatory variants in the human genome

    by Nanxiang Zhao, Rintsen N. Sherpa, Shengcheng Dong, Kobe B. Howcroft, Alan P. Boyle

    Identifying non-coding regulatory variants in the human genome remains a challenging task in genomics. Recently, we released the second version of our leading regulatory variant database, RegulomeDB. Building upon this comprehensive database, we developed a novel machine-learning architecture, TLand, which utilizes RegulomeDB-derived features to predict regulatory variants at the cell- or organ-specific level. In our holdout benchmarking, TLand consistently outperformed state-of-the-art models, demonstrating its ability to generalize to new cell lines or organs. We trained three types of organ-specific TLand models to overcome the common model bias toward high data availability cell lines or organs. These models accurately prioritize relevant organs for 2 million GWAS SNPs associated with GWAS traits. Moreover, our analysis of top-scoring variants in specific organ models showed a high enrichment of relevant GWAS traits. We expect that TLand and RegulomeDB will further advance our ability to understand human regulatory variants genome-wide.


  • Open Access

    Explain-seq: an end-to-end pipeline from training to interpretation of sequence-based deep learning models

    by Nanxiang Zhao, Shuze Wang, Qianhui Huang, Shengcheng Dong, Alan P. Boyle

    Interpreting predictive machine learning models to derive biological knowledge is the ultimate goal of developing models in the era of genomic data exploding. Recently, sequence-based deep learning models have greatly outperformed other machine learning models such as SVM in genome-wide prediction tasks. However, deep learning models, which are black-box models, are challenging to interpret their predictions. Here we represented an end-to-end computational pipeline, Explain-seq, to automate the process of developing and interpreting deep learning models in the context of genomics. Explain-seq takes input as genomic sequences and outputs predictive motifs derived from the model trained on sequences. We demonstrated Explain-seq with a public STARR-seq dataset of the A549 human lung cancer cell line released by ENCODE. We found our deep learning model outperformed gkm-SVM model in predicting A549 enhancer activities. By interpreting our well-performed model, we identified 47 TF motifs matched with known TF PWMs, including ZEB1, SP1, YY1, and INSM1. They are associated with epithelial-mesenchymal transition and lung cancer proliferation and metagenesis. In addition, there were motifs that were not matched in the JASPAR database and may be considered as de novo enhancer motifs in the A549 cell line. Availability: https://github.com/nsamzhao/Explain-seq Contact: apboyle@umich.edu Supplementary information: Supplementary data are available as attachment.

  • Open Access

    Annotating and prioritizing human non-coding variants with RegulomeDB

    by Shengcheng Dong, Nanxiang Zhao, Emma Spragins, Meenakshi S. Kagda, Mingjie Li, Pedro Assis, Otto Jolanki, Yunhai Luo, J Michael Cherry, Alan P Boyle, et al.

    Nearly 90% of the disease risk-associated variants identified from genome-wide association studies (GWAS) are in non-coding regions of the genome. The annotations obtained from analyzing functional genomics assays can provide additional information to pinpoint causal variants, which are often not the lead variants identified from association studies. However, the lack of available annotation tools limits the use of such data. To address the challenge, we have previously built the RegulomeDB database for prioritizing and annotating variants in non-coding regions 1 , which has been a highly utilized resource for the research community (Supplementary Fig. 1). RegulomeDB annotates a variant by intersecting its position with genomic intervals identified from functional genomic assays and computational approaches. It also incorporates those hits of a variant into a heuristic ranking score, representing its potential to be functional in regulatory elements. Here we present a newer version of the RegulomeDB web server, RegulomeDB v2.1 ( http://regulomedb.org ). We improve and boost annotation power by incorporating thousands of newly processed data from functional genomic assays in GRCh38 assembly, and now include probabilistic scores from the SURF algorithm that was the top performing non-coding variant predictor in CAGI 5 2 . We also provide interactive charts and genome browser views to allow users an easy way to perform exploratory analyses in different tissue contexts.


  • Open Access

    Prioritization of regulatory variants with tissue-specific function in the non-coding regions of human genome

    by Shengcheng Dong, Alan P. Boyle

    Understanding the functional consequences of genetic variation in the non-coding regions of the human genome remains a challenge. We introduce here a computational tool, TURF, to prioritize regulatory variants with tissue-specific function by leveraging evidence from functional genomics experiments, including over three thousand functional genomics datasets from the ENCODE project provided in the RegulomeDB database. TURF is able to generate prediction scores at both organism and tissue/organ-specific levels for any non-coding variant on the genome. We present that TURF has an overall top performance in prediction by using validated variants from MPRA experiments. We also demonstrate how TURF can pick out the regulatory variants with tissue-specific function over a candidate list from associate studies. Furthermore, we found that various GWAS traits showed the enrichment of regulatory variants predicted by TURF scores in the trait-relevant organs, which indicates that these variants can be a valuable source for future studies.


  • Open Access

    Predicting the effects of SNPs on transcription factor binding affinity

    by Sierra S Nishizaki, Natalie Ng, Shengcheng Dong, Robert S Porter, Cody Morterud, Colten Williams, Courtney Asman, Jessica A Switzenberg, Alan P Boyle

    Genome-wide association studies have revealed that 88% of disease-associated single-nucleotide polymorphisms (SNPs) reside in noncoding regions. However, noncoding SNPs remain understudied, partly because they are challenging to prioritize for experimental validation. To address this deficiency, we developed the SNP effect matrix pipeline (SEMpl). SEMpl estimates transcription factor-binding affinity by observing differences in chromatin immunoprecipitation followed by deep sequencing signal intensity for SNPs within functional transcription factor-binding sites (TFBSs) genome-wide. By cataloging the effects of every possible mutation within the TFBS motif, SEMpl can predict the consequences of SNPs to transcription factor binding. This knowledge can be used to identify potential disease-causing regulatory loci. SEMpl is available from https://github.com/Boyle-Lab/SEM_CPP. Supplementary data are available at Bioinformatics online.


  • Predicting functional variants in enhancer and promoter elements using RegulomeDB

    by Shengcheng Dong, Alan P. Boyle

    Here we present a computational model, Score of Unified Regulatory Features (SURF), that predicts functional variants in enhancer and promoter elements. SURF is trained on data from massively parallel reporter assays and predicts the effect of variants on reporter expression levels. It achieved the top performance in the Fifth Critical Assessment of Genome Interpretation “Regulation Saturation” challenge. We also show that features queried through RegulomeDB, which are direct annotations from functional genomics data, help improve prediction accuracy beyond transfer learning features from DNA sequence‐based deep learning models. Some of the most important features include DNase footprints, especially when coupled with complementary ChIP‐seq data. Furthermore, we found our model achieved good performance in predicting allele‐specific transcription factor binding events. As an extension to the current scoring system in RegulomeDB, we expect our computational model to prioritize variants in regulatory regions, thus help the understanding of functional variants in noncoding regions that lead to disease.


  • Integration of multiple epigenomic marks improves prediction of variant impact in saturation mutagenesis reporter assay

    by Dustin Shigaki, Orit Adato, Aashish N. Adhikari, Shengcheng Dong, Alex Hawkins‐Hooker, Fumitaka Inoue, Tamar Juven‐Gershon, Henry Kenlay, Beth Martin, Ayoti Patra, et al.

    Integrative analysis of high‐throughput reporter assays, machine learning, and profiles of epigenomic chromatin state in a broad array of cells and tissues has the potential to significantly improve our understanding of non‐coding regulatory element function and its contribution to human disease. Here we report results from the CAGI 5 regulation saturation challenge where participants were asked to predict the impact of nucleotide substitution at every base pair within five disease associated human enhancers and nine disease associated promoters. A library of mutations covering all bases was generated by saturation mutagenesis and altered activity was assessed in a massively parallel reporter assay (MPRA) in relevant cell lines. Reporter expression was measured relative to plasmid DNA to determine the impact of variants. The challenge was to predict the functional effects of variants on reporter expression. Comparative analysis of the full range of submitted prediction results identifies the most successful models of transcription factor binding sites, machine learning algorithms, and ways to choose among or incorporate diverse datatypes and cell‐types for training computational models. These results have the potential to improve the design of future studies on more diverse sets of regulatory elements and aid the interpretation of disease associated genetic variation.


  • Open Access

    Predicting the effects of SNPs on transcription factor binding affinity

    by Sierra S Nishizaki, Natalie Ng, Shengcheng Dong, Cody Morterud, Colten Williams, Alan P Boyle

    GWAS have revealed that 88% of disease associated SNPs reside in noncoding regions. However, noncoding SNPs remain understudied, partly because they are challenging to prioritize for experimental validation. To address this deficiency, we developed the SNP effect matrix pipeline (SEMpl). SEMpl estimates transcription factor binding affinity by observing differences in ChIP-seq signal intensity for SNPs within functional transcription factor binding sites genome-wide. By cataloging the effects of every possible mutation within the transcription factor binding site motif, SEMpl can predict the consequences of SNPs to transcription factor binding. This knowledge can be used to identify potential disease-causing regulatory loci.